These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20554191)

  • 1. Proteomic analysis of anti-tumor effects by tetrandrine treatment in HepG2 cells.
    Cheng Z; Wang K; Wei J; Lu X; Liu B
    Phytomedicine; 2010 Nov; 17(13):1000-5. PubMed ID: 20554191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role of tetrandrine in cancer therapy.
    Chen YJ
    Acta Pharmacol Sin; 2002 Dec; 23(12):1102-6. PubMed ID: 12466047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of anti-tumor effects by Rhizoma Paridis total saponin treatment in HepG2 cells.
    Cheng ZX; Liu BR; Qian XP; Ding YT; Hu WJ; Sun J; Yu LX
    J Ethnopharmacol; 2008 Nov; 120(2):129-37. PubMed ID: 18761071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiproliferative and apoptotic effects of tetrandrine on different human hepatoma cell lines.
    Ng LT; Chiang LC; Lin YT; Lin CC
    Am J Chin Med; 2006; 34(1):125-35. PubMed ID: 16437745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic analysis of hepatocellular carcinoma HepG2 cells treated with platycodin D.
    Lu JJ; Lu DZ; Chen YF; Dong YT; Zhang JR; Li T; Tang ZH; Yang Z
    Chin J Nat Med; 2015 Sep; 13(9):673-9. PubMed ID: 26412427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tetrandrine selectively protects against amyloid-beta protein - but not against MPTP-induced cytotoxicity in SK-N-SH neuroblastoma cells.
    Chiou WF; Lee WS; Yeh PH
    Planta Med; 2006 Nov; 72(14):1300-4. PubMed ID: 17051460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic identification of proteins involved in the anticancer activities of oridonin in HepG2 cells.
    Wang H; Ye Y; Pan SY; Zhu GY; Li YW; Fong DW; Yu ZL
    Phytomedicine; 2011 Jan; 18(2-3):163-9. PubMed ID: 20724128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of antibacterial activity of tetrandrine against Staphylococcus aureus.
    Lee YS; Han SH; Lee SH; Kim YG; Park CB; Kang OH; Keum JH; Kim SB; Mun SH; Seo YS; Myung NY; Kwon DY
    Foodborne Pathog Dis; 2012 Aug; 9(8):686-91. PubMed ID: 22845553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of tetrandrine plus radiation on neuroblastoma cells.
    Chen Y; Chen JC; Tseng SH
    Anticancer Res; 2009 Aug; 29(8):3163-71. PubMed ID: 19661330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic anti-candidal activity of tetrandrine on ketoconazole: an experimental study.
    Zhang H; Wang K; Zhang G; Ho HI; Gao A
    Planta Med; 2010 Jan; 76(1):53-61. PubMed ID: 19644794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
    Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
    J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance.
    Fu L; Liang Y; Deng L; Ding Y; Chen L; Ye Y; Yang X; Pan Q
    Cancer Chemother Pharmacol; 2004 Apr; 53(4):349-56. PubMed ID: 14666379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tetrandrine on glioma cell malignant phenotype via inhibition of ADAM17.
    Wu Z; Wang G; Xu S; Li Y; Tian Y; Niu H; Yuan F; Zhou F; Hao Z; Zheng Y; Li Q; Wang J
    Tumour Biol; 2014 Mar; 35(3):2205-10. PubMed ID: 24185966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of doxorubicin resistance by tetrandrine and dauricine in harringtonine-resistant human leukemia (HL60) cells.
    He QY; Meng FH; Zhang HQ
    Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):179-81. PubMed ID: 9772674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrandrine protects mice from concanavalin A-induced hepatitis through inhibiting NF-kappaB activation.
    Feng D; Mei Y; Wang Y; Zhang B; Wang C; Xu L
    Immunol Lett; 2008 Dec; 121(2):127-33. PubMed ID: 18992279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis.
    Hsu YC; Chiu YT; Cheng CC; Wu CF; Lin YL; Huang YT
    J Gastroenterol Hepatol; 2007 Jan; 22(1):99-111. PubMed ID: 17201889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic analysis of proteins secreted by HepG2 cells treated with butyl benzyl phthalate.
    Choi S; Park SY; Kwak D; Phark S; Lee M; Lim JY; Jung WW; Sul D
    J Toxicol Environ Health A; 2010; 73(21-22):1570-85. PubMed ID: 20954082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The study of anti-tumor effect of Tetrandrine combined with Nedaplatin on human liver cancer cell line 7402].
    Deng WY; Luo SX; Zhou MQ; Li N; Chen XB; Han LL
    Zhong Yao Cai; 2008 Oct; 31(10):1522-5. PubMed ID: 19230406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on chemotherapeutic agent-associated genes in human gastric cancer cell lines.
    Wei J; Liu B; Wang L; Qian X; Ding Y; Yu L
    Cancer Chemother Pharmacol; 2007 Oct; 60(5):703-11. PubMed ID: 17256130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative proteomics analysis of the proteins associated with laryngeal carcinoma-related gene 1.
    Zhang X; Xiao Z; Chen Z; Li C; Li J; Yanhui Y; Yang F; Yang Y; Oyang Y
    Laryngoscope; 2006 Feb; 116(2):224-30. PubMed ID: 16467709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.